HIF1A and neuroblastoma: In MYC-amplified neuroblastomas, the correlation between SHMT2 and HIF1α was associated with poor patient prognosis, confirming the essential role of HIF1-induced SHMT2 regulation in maintaining therapy-resistant hypoxic cell survival [115].